Please use this identifier to cite or link to this item: https://hdl.handle.net/11000/32345
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZandonai, Thomas-
dc.contributor.authorPeiró, Ana-
dc.contributor.authorCovelli, Caterina-
dc.contributor.authorde la Torre, Xavier-
dc.contributor.authorBotré, Francesco-
dc.contributor.otherDepartamentos de la UMH::Farmacología, Pediatría y Química Orgánicaes_ES
dc.date.accessioned2024-06-26T07:13:04Z-
dc.date.available2024-06-26T07:13:04Z-
dc.date.created2022-12-05-
dc.identifier.citationInternational Journal of Sports Physiology and Performance 2022 Dec 5;18(1):95-98es_ES
dc.identifier.issn1555-0265-
dc.identifier.issn1555-0273-
dc.identifier.urihttps://hdl.handle.net/11000/32345-
dc.description.abstractPurpose: To assess the prevalence of tramadol use among athletes from 2012 to 2020. Methods: All urine samples were collected from national and international in-competition doping-control tests that took place in Italy between 2012 and 2020. The analysis of the samples was performed by gas chromatography coupled with mass spectrometry with electronic ionization and acquisition in selected ionmonitoring. The cutoff tramadol concentration was >50 ng/mL. Results: Of the 60,802 in-competition urine samples we analyzed, 1.2% (n = 759) showed tramadol intake, with 84.2% (n = 637) of these coming from cyclists and 15.8%(n = 122) from other sports. In cycling, a strong and significant negative correlation was found (r = −.738; P = .003), showing a decrease of tramadol use compared with the other sports. Conclusions: The decrease in tramadol prevalence in cycling in the last years may be due to (1) the deterrent action of antidoping regulations and (2) the fact that tramadol may not have any actual ergogenic effect on performance.es_ES
dc.formatapplication/pdfes_ES
dc.format.extent4es_ES
dc.language.isoenges_ES
dc.publisherHuman Kineticses_ES
dc.rightsinfo:eu-repo/semantics/closedAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectanalgesicses_ES
dc.subjectopioidses_ES
dc.subjectathleteses_ES
dc.subjectWADAes_ES
dc.subjectsportes_ES
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::615 - Farmacología. Terapéutica. Toxicología. Radiologíaes_ES
dc.titleTramadol and Cycling: Is It the End of a “Painful” Relationship?. An Insight From 60,802 Doping-Control Samples From 2012 to 2020es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttps://doi.org/10.1123/ijspp.2022-0243es_ES
Appears in Collections:
Artículos Farmacología, Pediatría y Química Orgánica


no-thumbnailView/Open:

 Tramadol and Cycling Is It the End of a “Painful” Relationship. An Insight From 60,802 Doping-Control Samples From 2012 to 2020.pdf



502,51 kB
Adobe PDF
Share:


Creative Commons ???jsp.display-item.text9???